Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity
Leonardo Bontempi, Paola Savoia, Federica Bono, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 4, pp. 313-324
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel, Silvia Gatti McArthur
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 190
Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system
Danko Jeremic, Irene Sánchez‐Rodríguez, Lydia Jiménez‐Díaz, et al.
Pharmacology & Therapeutics (2021) Vol. 223, pp. 107808-107808
Open Access | Times Cited: 65
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
Béla Kiss, I. Laszlovszky, Balázs Krámos, et al.
Biomolecules (2021) Vol. 11, Iss. 1, pp. 104-104
Open Access | Times Cited: 51
Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum
Sergi Ferré, Laura I. Sarasola, César Quiroz, et al.
Neuropharmacology (2022) Vol. 223, pp. 109329-109329
Open Access | Times Cited: 34
Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection
Federica Bono, Veronica Mutti, Chiara Fiorentini, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1016-1016
Open Access | Times Cited: 39
Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors
Federica Bono, Chiara Fiorentini, Veronica Mutti, et al.
Pharmacological Research (2023) Vol. 190, pp. 106711-106711
Open Access | Times Cited: 11
Membrane Heteroreceptor Complexes as Second-Order Protein Modulators: A Novel Integrative Mechanism through Allosteric Receptor–Receptor Interactions
Marina Mirchandani‐Duque, Malak Choucri, Juan C. Hernández-Mondragón, et al.
Membranes (2024) Vol. 14, Iss. 5, pp. 96-96
Open Access | Times Cited: 4
Understanding electrical and chemical transmission in the brain
Dasiel O. Borroto‐Escuela, Emmanuell Gonzalez-Cristo, Verty Ochoa-Torres, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Role of dopamine receptor heteromerization in preclinical models of addiction and other psychiatric disorders
Adèle Vilette, Anna Petitbon, Marie‐Charlotte Allichon, et al.
Exploration of Neuroprotective Therapy (2025) Vol. 5
Open Access
Abnormalities of Dopamine D3Receptor Signaling in the Diseased Brain
G. Aleph Prieto
Journal of Central Nervous System Disease (2017) Vol. 9, pp. 117957351772633-117957351772633
Open Access | Times Cited: 38
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer
Federica Bono, Veronica Mutti, Paola Savoia, et al.
Neurobiology of Disease (2019) Vol. 129, pp. 1-12
Closed Access | Times Cited: 33
Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D2 and D3 Receptors and Their Impact on Behavioral Sensitization
Kyeong‐Man Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6742-6742
Open Access | Times Cited: 10
17-β-estradiol potentiates the neurotrophic and neuroprotective effects mediated by the dopamine D3/acetylcholine nicotinic receptor heteromer in dopaminergic neurons.
Giulia Sbrini, Veronica Mutti, Federica Bono, et al.
European Journal of Pharmacology (2024) Vol. 976, pp. 176678-176678
Open Access | Times Cited: 3
Alterations in Neuronal Nicotinic Acetylcholine Receptors in the Pathogenesis of Various Cognitive Impairments
Zhi‐Zhong Guan
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 3
Extramembranous Regions in G Protein-Coupled Receptors: Cinderella in Receptor Biology?
Sreetama Pal, Amitabha Chattopadhyay
The Journal of Membrane Biology (2019) Vol. 252, Iss. 4-5, pp. 483-497
Closed Access | Times Cited: 26
Heteromerization of dopaminergic receptors in the brain: Pharmacological implications
Desye Misganaw
Pharmacological Research (2021) Vol. 170, pp. 105600-105600
Closed Access | Times Cited: 21
Expression and function of nicotinic acetylcholine receptors in specific neuronal populations: Focus on striatal and prefrontal circuits
Alice Abbondanza, Anna Urushadze, Amanda Rosanna Alves-Barboza, et al.
Pharmacological Research (2024) Vol. 204, pp. 107190-107190
Open Access | Times Cited: 2
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson’s disease patients carrying the LRRK2 G2019S mutation
Federica Bono, Veronica Mutti, Paola Devoto, et al.
Neurobiology of Aging (2020) Vol. 99, pp. 65-78
Closed Access | Times Cited: 20
Disrupting GPCR Complexes with Smart Drug-like Peptides
Maria Gallo, Sira Defaus, David Andreu
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 161-161
Open Access | Times Cited: 11
Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway
Veronica Mutti, Federica Bono, Zaira Tomasoni, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 4, pp. 2129-2149
Open Access | Times Cited: 10
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons
Carlo Matera, Federica Bono, Silvia Pelucchi, et al.
Biochemical Pharmacology (2019) Vol. 163, pp. 154-168
Open Access | Times Cited: 16
Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress
J. Brucker Nourse, Gilad Harshefi, Adi Marom, et al.
iScience (2021) Vol. 24, Iss. 3, pp. 102140-102140
Open Access | Times Cited: 12
α4β2 nicotinic acetylcholine receptor downregulates D3 dopamine receptor expression through protein kinase C activation
Srijan Acharya, Kyeong‐Man Kim
Biochemical and Biophysical Research Communications (2019) Vol. 514, Iss. 3, pp. 665-671
Closed Access | Times Cited: 12
The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats
Gregory L. Powell, Mark D. Namba, Annika Vannan, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1076-1076
Open Access | Times Cited: 12
Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and Heterodimers
Roberto Maggio, Irene Fasciani, Marco Carli, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1828-1828
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top